Nippon Shinyaku competitive analysis

Explore patent oppositions filed by Nippon Shinyaku against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 17, 2026
Patent NumberTitleApplicantOpposition Date
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENNov 28, 2016
Induction Of Exon Skipping In Eukaryotic CellsACADEMISCH ZIEKENHUIS LEIDENSep 30, 2016
Antisense Oligonucleotides For Inducing Exon Skipping And Methods Of Use ThereofTHE UNIVERSITY OF WESTERN AUSTRALIAAug 25, 2016

Explore Nippon Shinyaku's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 17, 2026
Patent NumberPublication DateTitleTotal Oppositions
Apr 30, 2025Pharmaceutical Composition Containing 2-{4-[N-(5,6-Diphenylpyrazin-2-Yl)-N-Isopropylamino]Butyloxy}-N-(Methylsulfonyl)Acetamide2
Jan 15, 2020Crystals1
Aug 7, 2019Antisense Nucleic Acids2
Dec 6, 2017Crystals3

Latest PTAB cases involving Nippon Shinyaku

Discover the latest PTAB cases involving Nippon Shinyaku, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Nippon Shinyaku with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 17, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
NIPPON SHINYAKU38 - -
ACADEMISCH ZIEKENHUIS LEIDEN - 12 - -
ALFRED E TIEFENBACHER765 - -
GENERICS UK319 - - -